Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:165  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 


 
   Table of Contents     
ORIGINAL ARTICLE  
Year : 2018  |  Volume : 10  |  Issue : 2  |  Page : 74-79
Detection of biofilm-associated implant pathogens in cardiac device infections: High sensitivity of sonication fluid culture even in the presence of antimicrobials


1 Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy
2 Electrophysiology Section, Cardiology Department, Sapienza University, Rome, Italy

Click here for correspondence address and email

Date of Web Publication23-May-2018
 

   Abstract 


Introduction: Sonication showed more sensitivity than traditional culture in the diagnosis of device infections. Aims of the study were to assess the role of sonication in the microbiological diagnosis and management of cardiac device infections (CDIs), to evaluate the sensitivity of sonication in patients on antimicrobial therapy at the time of device removal, and to analyze biofilm formation of the isolated strains. Materials and Methods: A total of 90 devices (31 generators and 59 electrodes) collected from 31 patients with infection underwent sonication before culture. Devices were sonicated for 5 min and centrifuged at 3200 rpm for 15 min. Intraoperative traditional cultures were performed in 26 patients. Microorganisms were identified using conventional methods. Staphylococcal strains were tested for slime production. Results: Microbiological diagnosis was achieved in 28 patients (90%). Sonicate fluid was positive in 68/90 (76%) of devices (27/31 [87%] generators and 41/59 [69%] electrodes), whereas intraoperative pocket swabs grew bacteria in 10/26 patients (38%, P= 0.0007). Among leads, 37/59 (62.7%) yielded bacteria even in the absence of vegetation. Coagulase-negative Staphylococci accounted for 83.8% (57/68) of the total; Staphylococcus aureus and Gram-negative bacilli were found in 4.4% (3/68) and 5.8% (4/68), respectively. Biofilm production was present in 15/22 (69%) staphylococcal strains. Overall, patients on therapy (n = 23) had a microbiological diagnosis in 20/23 (86.9%) and 7/22 (30.4%) through sonication and intraoperative cultures, respectively (P = 0.0002). Discussion: Our data showed the high sensitivity of sonication in the diagnosis of CDIs, even in patients under antimicrobial therapy. Conclusion: Sonication represents an essential tool for both diagnosis and management of CDIs.

Keywords: Biofilm, cardiac device infections, sonication technique, staphylococcus, traditional cultures

How to cite this article:
Oliva A, Mascellino MT, Nguyen BL, De Angelis M, Cipolla A, Di Berardino A, Ciccaglioni A, Mastroianni CM, Vullo V. Detection of biofilm-associated implant pathogens in cardiac device infections: High sensitivity of sonication fluid culture even in the presence of antimicrobials. J Global Infect Dis 2018;10:74-9

How to cite this URL:
Oliva A, Mascellino MT, Nguyen BL, De Angelis M, Cipolla A, Di Berardino A, Ciccaglioni A, Mastroianni CM, Vullo V. Detection of biofilm-associated implant pathogens in cardiac device infections: High sensitivity of sonication fluid culture even in the presence of antimicrobials. J Global Infect Dis [serial online] 2018 [cited 2019 Oct 19];10:74-9. Available from: http://www.jgid.org/text.asp?2018/10/2/74/232993





   Introduction Top


Cardiac implantable electronic device (CIED) infections are life-threatening conditions associated with significant morbidity, mortality and rising global health-care cost.[1]

Their incidence has increased over the time, with an estimated rate of infections between 0.13% and 19.9%.[2],[3]

A clear diagnosis of cardiac device infections (CDIs) is of crucial importance to start an appropriate antimicrobial therapy.[4] Traditional pocket swabs and tissue specimens exhibit low sensitivity and specificity for diagnosing CIED infections,[5] whereas blood cultures are generally positive only in case of systemic dissemination [6] and up to 30% of CDIs are culture negative.[7] Moreover, a previous antimicrobial therapy may hamper the diagnostic yield of traditional cultures.[3],[4]

CIED infections are characterized by the formation of biofilm, in which bacteria are present in a stationary growth phase and are more resistant to antibiotics than their planktonic counterpart.[8]

The sonication method, which is based on the application of long-wave ultrasound, has been used to enhance bacterial detection by liberating sessile organisms embedded in biofilms on foreign bodies.[9],[10] In the setting of prosthetic joint infections (PJIs), pathogen detection rate was shown to be higher in the sonication fluid than in traditional culture.[9] In a previous study, we were able to demonstrate that sonication fluid culture had higher sensitivity than conventional culture in CDIs.[11] According to these results, in our hospital, the sonication method has been introduced in the routine clinical practice both in PJIs and CDIs.

On the basis of these considerations, the present study was undertaken with the following objectives: (i) to further assess the role of sonication in the microbiological diagnosis of CDIs in the clinical practice; (ii) to identify patients at major risk of developing device-related endocarditis throughout the sonication of different device components; (iii) to evaluate the sensitivity of sonication method in patients on antimicrobial therapy at the moment of device removal; and (iv) to analyze biofilm formation of the staphylococcal strains isolated from culture after sonication.


   Materials and Methods Top


All consecutive patients who underwent explantation of permanent pacemaker (PPM) or implantable cardioverter defibrillator (ICD) because of infection at the Electrophysiology Service at Sapienza University of Rome were included in the study. Patients gave informed written consent, and the study protocol was approved by the local ethics committee.

Diagnosis of CDI was made according to the international definitions of pocket infection and device-related endocarditis.[12],[13]

Device removal was performed under aseptic condition in the cardiac electrophysiology laboratory by interventional electrophysiologists who have been specialized in CIED implantation and extraction. Lead extraction was performed manually with or without the assistance of traction devices including stylets, locking stylets (Lead Locking Device 1, 2, and EZ LLDTM, Spectranetics®, Colorado Springs, CO, USA), snares, laser, or radiofrequency.[14],[15]

A complete device removal including generators, atrial and/or ventricular leads was performed, and the collected devices, placed in different sterile containers, were submitted to culture after sonication. Blood cultures (n = 3 for each patient) and intraoperative pocket swabs were performed in 24 (77.4%) and 26 (83.8%) patients, respectively.

All samples reached the microbiology laboratory within 3 h from the collection.

The sonication process was performed as previously described.[16],[17] Briefly, after collection, devices were covered with sterile NaCl 0.9% or Ringer's solution then vortexed for 30 s, sonicated for 5 min at a frequency 40 ± 2 kHz and power density 0.22 ± 0.04 W/cm 2, vortexed again for 30 s, and centrifuged at 3200 rpm for 15 min. The BactoSonic (BANDELIN electronic GmbH & Co. KG) was used for sonication. Anaerobic and aerobic sheep blood agar plates were incubated at 37°C for up to 10 days, and the microorganisms were identified using conventional methods. The VITEK-2 (Bio-Merieux, Marcy l'Etoile, France) system was used to perform the antimicrobial susceptibility testing. Given that daptomycin MIC was not performed by VITEK-2 system, we evaluated daptomycin MICs 50/90 by macrobroth dilution method with a final bacterial inoculum of ≈5 × 105 CFU/mL.

Staphylococcal strains were tested for slime production by a modification of the Christensen method.[18] Briefly, 10 ml volume of tryptic soy broth (TSB) in plastic test tubes was inoculated with single colonies and incubated statically for 48 h at 37°C, after which the contents were decanted, and 1 ml volume of a 0.4% aqueous solution of trypan blue (Sigma Chemical Co, St Louis, Missouri, USA) was added. Each tube was then gently rotated to ensure uniform staining of any adherent material on the inner surface and the contents decanted. The tubes were then placed upside down to drain. A positive result was indicated by the presence of an adherent layer of stained material on the inner surface of the tube. The presence of stained material at the liquid–air interface alone was not regarded as indicative of slime production. Tubes filled with TSB only were considered as negative controls. The amount of slime production was classified as absent (0) and present (1).

All experiments were run in triplicate.

Statistical analyses were performed using GraphPad Prism version 7 (GraphPad Software MacKiev). Categorical variables were compared using the χ2 or Fisher's exact test, as appropriate. Continuous data were analyzed with Student's t-test or the nonparametric Mann–Whitney in case of values not normally distributed. P < 0.05 was considered statistically significant.


   Results Top


Characteristics of population

A total of 31 patients (21 M, 10 F, mean age 74.5 ± 11.2 years) underwent device removal throughout transvenous lead extraction because of infection: 29 had pocket infection and 2 had device-related endocarditis. The collected devices were 90, distributed as follows: 31 generators (28 PPM and 3 ICD) and 59 electrodes [Figure 1]. In addition, in 26 patients, pocket swab was performed. Twenty-two out of 31 patients (70%) had a previous pocket revision before the onset of the infection with a median duration of device placement of 623 days (range: 41–2950). Fever was present only in 37.9% of the patients (11/31), whereas signs of pocket infection were predominant (decubitus in 19/31, pocket tenderness in 21/31, and fistula in 10/31). Median time from device explantation to re-implantation was 5.65 days (range: 0–29).
Figure 1: Diagnostic flowchart. A totl of 90 device components (31 generators and 59 leads) collected from 31 patients (29 with pocket infection, 2 with device related endocarditis) were included in the study. Intra-operatory pocket swabs were performed in 26 patients. Leads included atrial and/or ventricular leads

Click here to view


General characteristics of population are summarized in [Table 1].
Table 1: General characteristics of study population (n=31)

Click here to view


Microbiological analysis

Blood cultures were positive for bacterial growth in 5 out of 24 patients (20%): Staphylococcus epidermidis and Corynebacterium striatum (>3 blood cultures each) in the patients with device-related endocarditis and coagulase-negative Staphylococci (CoNS) in 3 patients with pocket infection (1 blood culture each).

Culture after sonication of the device led to a definite microbiological diagnosis in 28 patients (90%).

Pocket swab yielded bacteria in 10 out of 26 (38%) patients, whereas sonicate fluid was positive in 68/90 (76%) of devices (P = 0.0007). Considering the different components of the devices, 27/31 (87%) generators and 41/59 (69%) electrodes (atrial and/or ventricular) grew bacteria in the sonication fluid (P = 0.07). In one case, generator culture was sterile and microbiological diagnosis was only possible after the culture of electrodes. Cultures from generators and electrodes yielded the same microorganism in the totality of cases. With the exception of 4 electrodes collected from the 2 patients with device-related endocarditis, 37 out of 59 leads (62.7%) yielded bacteria even in the absence of vegetations at echocardiography.

CoNS accounted for 83.8% (57/68) of the total whereas Staphylococcus aureus and Gram-negative bacilli including Pseudomonas aeruginosa and Klebsiella spp. were found in 4.4% (3/68) and 5.8% (4/68) of the total, respectively. As expected, S. epidermidis was the predominant microorganism causing CDI (48/68, 70.5%) followed by Staphylococcus hominis (7/68, 10.3%). Staphylococcus haemolyticus and Staphylococcus capitis accounted each for 1.4% of the total. A multidrug-resistant C. striatum causing device-related endocarditis was found in 3 out of 68 samples (4.4%) [Table 2].
Table 2: Microbiology of cardiac device infections

Click here to view


Among CoNS, resistance to oxacillin was found in 41 out of 57 (72%). Daptomycin was in vitro effective against all the Staphylococcus spp. strains, with a MIC 50/90 of 0.25 μg/ml.

Microbial biofilm production

Biofilm production was evaluated in 22 staphylococcal strains: 15 (69%) strains were biofilm producers. When considering the bacterial species, 73% of S. epidermidis, 67% of S. aureus, and S. hominis produced biofilm. No statistical differences among staphylococcal species were observed in biofilm production (P = 0.9).

Antimicrobial therapy and sensitivity of sonication fluid culture

Among the patients with CDI (n = 31), 23 out of 28 patients (82.1%) were on therapy at the moment of device removal. Overall, bacterial growth was shown in 20/23 (86.9%) and 7/22 (30.4%) patients on therapy through sonication and intraoperative cultures, respectively (P = 0.0002) [Table 2].

On the other hand, all the patients who were not on therapy at the moment of device removal had a positive culture (5/5, 100%) after sonication treatment, compared with 3/4 (75%) through intraoperative cultures (P = 0.44).

According to the duration of antimicrobial therapy before the explantation (> or <14 days), we found that 15/18 (83.3%) patients who were on therapy >14 days had a positive culture whereas all the patients who were on therapy <14 days had a positive culture (5/5, 100%, P= 0.13).


   Discussion Top


The incidence of CDIs has increased over the time independently of the growing relative proportion of implantable cardiovascular devices implants.[2] Due to the wide variety of presenting symptoms,[19] identifying the causative microorganism of CDIs is essential to institute appropriate antimicrobial therapy. Sonication before culture showed higher sensitivity in bacterial detection than conventional cultures [10],[11] due to the fact that bacteria, which are adherent to the device and embedded in the biofilm, can be efficiently dislodged from foreign body throughout this technique.[20],[21],[22]

However, the usefulness of sonication might rely not only on the microbiological diagnosis but also on understanding the pathogenesis of CDI. In this setting, it is important to collect and analyze both generators and electrodes to establish how and when electrodes are colonized or infected by bacteria. In fact, knowing which type of patient is at major risk of developing endocarditis compared to those who only develop pocket infection might have important clinical and therapeutic implications. Although several studies had been focused on the pathophysiology of CDIs, there is still a lack of certain data about the source of device infection, with local perioperative wound contamination and hematogenous seeding being the two involved mechanisms.[4],[19],[23] In our study, generators yielded bacteria in 87% (28/31) whereas electrodes showed bacterial growth in 69% (41/59). Among leads, 37/59 (62.7%) yielded bacteria even in the absence of vegetations at echocardiography. This finding is consistent with the hypothesis that bacteria first infect generators and then lead tips and that patients who present with signs and symptoms of pocket infection usually have involvement of the intravascular components of the system.[21]

Our data confirmed the high sensitivity of sonicate culture (90%) in the diagnosis of CDI; thus, sonication should always be performed in the microbiology laboratory to provide information regarding the causative agents and the best therapeutic approach in CDIs. However, still, a percentage of infection had no bacterial isolation, especially in patients on therapy >14 days before device removal.[5] In this setting of patients, the use of additional techniques such as molecular methods, which are less hampered by a previous antimicrobial therapy, might improve the bacterial detection rate.[24]

For biofilm detection, we performed the Christensen method in plastic tubes, which has been shown to correlate well with other methods such as scanning electron microscopy.[25] We classified the amount of slime production as absent or present, and we showed that 69% of staphylococcal strains were biofilm producers. However, this percentage might have been underestimated due to the difficulty in discriminating between weak and biofilm-negative isolates throughout the tube method.[25]

Although frequently regarded as contaminants, CoNS became of clinical relevance in the setting of device infections.[26] In fact, we found that the majority of CDIs were caused by Staphylococcus species (60/68, 88.2%), supporting the concept that wound contamination at the time of implantation or during the device procedure is crucial in the development of subsequent infection.

Furthermore, the finding that the majority of staphylococcal strains were biofilm producers suggests that biofilm formation is a key factor in the development of CDIs, representing a survival strategy through which microorganisms can attach to foreign bodies and better resist antibiotics and host defense system. In biofilm, microorganisms can be up to 1000-fold more resistant to antimicrobials than their planktonic counterparts.[8] Therefore, infections in the presence of an implant are persistent and difficult to eradicate, and removal of all foreign-body material is needed.

In our study, 72% of Staphylococcal strains were resistant to methicillin: this finding may be explained by the fact that a previous pocket revision was frequent in our population (70%). Since antimicrobial susceptibility pattern is relevant for the selection of empirical treatment and considering that most of CoNS and S. aureus causing CDIs are nowadays methicillin resistant, clinicians who treat these infections should be aware that beta-lactams might be ineffective and that first choices should include vancomycin or daptomycin.[4] Daptomycin has more advantages than vancomycin: first, it is active against biofilm bacteria; then, it is more rapidly bactericidal toward staphylococcal strains; and finally, daptomycin has fewer side effects, especially regarding renal toxicity.[27],[28] Thus, in the setting of CDIs, daptomycin might be considered as the best antimicrobial acting against staphylococcal biofilm. In the present study, all the tested staphylococcal strains were sensitive to daptomycin, highlighting the increasing role of this drug in the setting of biofilm-associated infections.

In our study, Gram-negative bacteria were detected in only 5.8% (4/68) of devices, showing a lower percentage than other published evidence,[5] which found Gram-negative bacilli as the causative organisms in 27.4% of CDIs. This finding might have important therapeutic implications in our institution, where empirical treatment usually does not cover Gram-negative bacilli.

As expected, the more the patient is on therapy before device explantation, the more is the possibility to have a negative culture. This is especially true for traditional culture, which is hampered by a previous or concomitant antimicrobial therapy. Conversely, the sonication technique, which acts by dislodging bacteria embedded in the biofilm, has been shown to retain its value in the microbiological diagnosis of prosthetic joint infections, even in the presence of antimicrobials.[9] In fact, planktonic bacteria are more sensitive to the inhibitory effect of anti-infective agents than are biofilm bacteria.[9] In the present study, sonication culture confirmed its high sensitivity even in those patients who were on antimicrobial therapy at the time of device removal, especially when compared with traditional intraoperative cultures (P = 0.0002).

Furthermore, among patients on antimicrobial therapy, 83.3% of patients who were on therapy >14 days and 100% of patients who were on therapy <14 days showed bacterial growth, thus highlighting the usefulness of sonication method even in the setting of previous antimicrobial use. This finding is of particular relevance because it is not uncommon that patients with CDI are given antimicrobial therapy before the complete removal of the device. Moreover, patients with a definite or suspected diagnosis of device-related endocarditis surely receive preoperative antimicrobial therapy; in this specific setting, the sonication of the explanted device might represent a pivotal add-on to reach the microbiological diagnosis of the infection and to establish the most appropriate therapy.


   Conclusion Top


Our data confirmed the high sensitivity of sonication before culture in the diagnosis of CDIs, even in patients on antimicrobial therapy. In addition, sonication might give physicians' important information regarding the pathogenesis of these infections by early detecting patients who are at major risk of developing device-related endocarditis.

Financial support and sponsorship

This study was financially supported by a grant from Sapienza University, Rome (2013).

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Johansen JB, Jørgensen OD, Møller M, Arnsbo P, Mortensen PT, Nielsen JC, et al. Infection after pacemaker implantation: Infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 2011;32:991-8.  Back to cited text no. 1
    
2.
Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: Temporal trends and causative insights. Pacing Clin Electrophysiol 2010;33:414-9.  Back to cited text no. 2
[PUBMED]    
3.
Lekkerkerker JC, van Nieuwkoop C, Trines SA, van der Bom JG, Bernards A, van de Velde ET, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 2009;95:715-20.  Back to cited text no. 3
[PUBMED]    
4.
Sandoe JA, Barlow G, Chambers JB, Gammage M, Guleri A, Howard P, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother 2015;70:325-59.  Back to cited text no. 4
[PUBMED]    
5.
Inacio RC, Klautau GB, Murça MA, da Silva CB, Nigro S, Rivetti LA, et al. Microbial diagnosis of infection and colonization of cardiac implantable electronic devices by use of sonication. Int J Infect Dis 2015;38:54-9.  Back to cited text no. 5
    
6.
Dy Chua J, Abdul-Karim A, Mawhorter S, Procop GW, Tchou P, Niebauer M, et al. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pacing Clin Electrophysiol 2005;28:1276-81.  Back to cited text no. 6
[PUBMED]    
7.
Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007;49:1851-9.  Back to cited text no. 7
[PUBMED]    
8.
Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001;358:135-8.  Back to cited text no. 8
[PUBMED]    
9.
Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007;357:654-63.  Back to cited text no. 9
[PUBMED]    
10.
Nagpal A, Patel R, Greenwood-Quaintance KE, Baddour LM, Lynch DT, Lahr BD, et al. Usefulness of sonication of cardiovascular implantable electronic devices to enhance microbial detection. Am J Cardiol 2015;115:912-7.  Back to cited text no. 10
[PUBMED]    
11.
Oliva A, Nguyen BL, Mascellino MT, D'Abramo A, Iannetta M, Ciccaglioni A, et al. Sonication of explanted cardiac implants improves microbial detection in cardiac device infections. J Clin Microbiol 2013;51:496-502.  Back to cited text no. 11
    
12.
Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings. Duke endocarditis service. Am J Med 1994;96:200-9.  Back to cited text no. 12
[PUBMED]    
13.
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr., Ryan T, et al. Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.  Back to cited text no. 13
    
14.
Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: Executive summary. Heart Rhythm 2008;5:934-55.  Back to cited text no. 14
[PUBMED]    
15.
Neuzil P, Taborsky M, Rezek Z, Vopalka R, Sediva L, Niederle P, et al. Pacemaker and ICD lead extraction with electrosurgical dissection sheaths and standard transvenous extraction systems: Results of a randomized trial. Europace 2007;9:98-104.  Back to cited text no. 15
[PUBMED]    
16.
Oliva A, Pavone P, D'Abramo A, Iannetta M, Mastroianni CM, Vullo V, et al. Role of sonication in the microbiological diagnosis of implant-associated infections: Beyond the orthopedic prosthesis. Adv Exp Med Biol 2016;897:85-102.  Back to cited text no. 16
    
17.
Mason PK, Dimarco JP, Ferguson JD, Mahapatra S, Mangrum JM, Bilchick KC, et al. Sonication of explanted cardiac rhythm management devices for the diagnosis of pocket infections and asymptomatic bacterial colonization. Pacing Clin Electrophysiol 2011;34:143-9.  Back to cited text no. 17
[PUBMED]    
18.
Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: A quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985;22:996-1006.  Back to cited text no. 18
[PUBMED]    
19.
Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association. Circulation 2010;121:458-77.  Back to cited text no. 19
[PUBMED]    
20.
Holinka J, Bauer L, Hirschl AM, Graninger W, Windhager R, Presterl E, et al. Sonication cultures of explanted components as an add-on test to routinely conducted microbiological diagnostics improve pathogen detection. J Orthop Res 2011;29:617-22.  Back to cited text no. 20
    
21.
Klug D, Wallet F, Kacet S, Courcol RJ. Involvement of adherence and adhesion Staphylococcus epidermidis genes in pacemaker lead-associated infections. J Clin Microbiol 2003;41:3348-50.  Back to cited text no. 21
[PUBMED]    
22.
Oliva A, Belvisi V, Iannetta M, Andreoni C, Mascellino MT, Lichtner M, et al. Pacemaker lead endocarditis due to multidrug-resistant Corynebacterium striatum detected with sonication of the device. J Clin Microbiol 2010;48:4669-71.  Back to cited text no. 22
[PUBMED]    
23.
Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S, et al. Cardiac implantable electronic device infections: Presentation, management, and patient outcomes. Heart Rhythm 2010;7:1043-7.  Back to cited text no. 23
[PUBMED]    
24.
Achermann Y, Vogt M, Leunig M, Wüst J, Trampuz A. Improved diagnosis of periprosthetic joint infection by multiplex PCR of sonication fluid from removed implants. J Clin Microbiol 2010;48:1208-14.  Back to cited text no. 24
    
25.
Mathur T, Singhal S, Khan S, Upadhyay DJ, Fatma T, Rattan A, et al. Detection of biofilm formation among the clinical isolates of Staphylococci: An evaluation of three different screening methods. Indian J Med Microbiol 2006;24:25-9.  Back to cited text no. 25
[PUBMED]  [Full text]  
26.
Anselmino M, Vinci M, Comoglio C, Rinaldi M, Bongiorni MG, Trevi GP, et al. Bacteriology of infected extracted pacemaker and ICD leads. J Cardiovasc Med (Hagerstown) 2009;10:693-8.  Back to cited text no. 26
[PUBMED]    
27.
Moise PA, Amodio-Groton M, Rashid M, Lamp KC, Hoffman-Roberts HL, Sakoulas G, et al. Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant β-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment. Antimicrob Agents Chemother 2013;57:1192-200.  Back to cited text no. 27
[PUBMED]    
28.
Murray KP, Zhao JJ, Davis SL, Kullar R, Kaye KS, Lephart P, et al. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: A matched cohort study. Clin Infect Dis 2013;56:1562-9.  Back to cited text no. 28
[PUBMED]    

Top
Correspondence Address:
Dr. Alessandra Oliva
Department of Public Health and Infectious Diseases, Sapienza University, Piazzale Aldo Moro 5, 00185 Rome
Italy
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jgid.jgid_31_17

Rights and Permissions


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1], [Table 2]



 

Top
  
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
   Introduction
    Materials and Me...
   Results
   Discussion
   Conclusion
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed914    
    Printed28    
    Emailed0    
    PDF Downloaded7    
    Comments [Add]    

Recommend this journal

Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008